Vodis USA and Our Church International Sign 15 Year Licensing and Marketing Agreement

Tickers: XCNQ:VP, PINX:VDQSFTags: Biotechnology, Research & Development, Technology February 23, 2017 / TheNewswire / Vancouver, British Columbia – Vodis Pharmaceuticals Inc. (CSE: VP / FSE: 1JV) ("Vodis" or the "Company") announced today the Vodis name, image and various Vodis-inspired designs and concepts will be used to brand, market, and sell…